2009 SIPREC Consensus Document – Executive Summary

摘要: Cardiovascular diseases still represent the leading cause of mortality and hospitalization, worldwide. As a consequence marked demographic changes observed in general population, improved survival rate after an acute cardiovascular event progressive rise costs (mostly due to technological pharmacological innovations), estimated burden will be soon become insurmountable for national healthcare systems. In this view, integrated approach aimed at improving strategies disease prevention and, thus, limiting negative outcomes, would probably successful. Such may not only achieve long-term benefits, but even significant advantages short medium term, mostly asymptomatic high-risk individuals. Indeed, latter population individuals benefit from extensive application improvement with favourable cost-benefit ratio. The Italian Society Disease Prevention — Societa Italiana per la Prevenzione Cardiovascolare (SIPREC) has recognized strategic aim, focusing part its institutional actions on effort providing educational supports consensus documents, which overview scientific knowledge personal clinical expertise by international key opinion leaders. Expert committees periodically generate ‘state-of-the-art’ documents specific topics relevant socioeconomic implications large impact. present article is dedicated professionals, based available evidence, provides information diagnostic algorithms therapeutic options abnormal glucose regulation (or dysglycaemia). relationship between abnormalities metabolism complications represents important relatively early target prevention. SIPREC identified, setting, group experts order form multidisciplinary ‘task force’. This been asked explain short, simple effective fashion epidemiological impact pathophysiological nature problem, features, potential options, influence practice both specialist physicians practitioners. work background discussing novel future It also highlighting importance emerging marker risk, often underestimated.